scholarly journals Pelvic Inflammatory Disease (PID) Management in Corona Virus Disease 2019 (COVID-19) Era

2021 ◽  
Vol 4 (1) ◽  
pp. 34-41
Author(s):  
I Gde Sastra Winata ◽  
◽  
Musa Taufiq
Keyword(s):  
Disease Management ◽  
Emergency Room ◽  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Emergency Room Visit ◽  
Virus Disease ◽  
Google Scholar ◽  
Face To Face ◽  
Corona Virus

Objective: This article aims to review pelvic inflammatory disease management during the coronavirus disease 2019 pandemic Method: We conducted a search for scientific articles through PubMed and Google Scholar, using the terminologies of “PID AND COVID-19”, “Pelvic Inflammatory Disease”; “Pelvic Inflammatory Disease AND COVID-19”, “PID Management AND COVID-19”, “Pelvic Inflammatory Disease Management AND COVID-19”, and “PID AND Pandemic” in English and Indonesian from 2019-2020. Result: There were a total of 25 scientific articles from PubMed and Google Scholar within 2019-2020 that were included as the source of this review Conclusion: There is no difference between the management of pelvic inflammatory disease during and before the pandemic. The mode of medical services and follow up tends to be conducted virtually. Technology-based services for pelvic inflammatory disease during the corona virus disease 2019 pandemic are promising and have been proven to be an effective method, therefore virtual-based pelvic inflammatory disease services may be safely applied. However, if there is any indication of emergency found during the telemedicine services, a face-to-face consultation or emergency room visit should be recommended. Key words : COVID-19, Pelvic Inflammatory Disease, SARS-CoV-2

Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial

2020 ◽  
pp. sextrans-2020-054468
Author(s):  
Gillian Dean ◽  
Suneeta Soni ◽  
Rachel Pitt ◽  
Jonathan Ross ◽  
Caroline Sabin ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Clinical Cure ◽  
Primary Outcome ◽  
Controlled Trial ◽  
High Rate ◽  
Resistance Testing ◽  
Short Course

ObjectiveA multicentre, randomised non-inferiority trial compared the efficacy and safety of 14 days of ofloxacin and metronidazole (standard-of-care (SoC)) versus a single dose of intramuscular ceftriaxone followed by 5 days of azithromycin and metronidazole (intervention arm (IA)) in women with mild-to-moderate pelvic inflammatory disease (PID).MethodsWomen with a clinical diagnosis of PID presenting at sexual health services were randomised to the SoC or IA arms. Treating clinicians and participants were not blinded to treatment allocation but the clinician performing the assessment of primary outcome was blinded. The primary outcome was clinical cure defined as ≥70% reduction in the modified McCormack pain score at day 14–21 after starting treatment. Secondary outcomes included adherence, tolerability and microbiological cure.ResultsOf the randomised population 72/153 (47.1%) reached the primary end point in the SoC arm, compared with 68/160 (42.5%) in the IA (difference in cure 4.6% (95% CI −15.6% to 6.5%). Following exclusion of 86 women who were lost to follow-up, attended outside the day 14–21 follow-up period, or withdrew consent, 72/107 (67.3%) had clinical cure in the SoC arm compared with 68/120 (56.7%) in the IA, giving a difference in cure rate of 10.6% (95% CI −23.2% to 1.9%). We were unable to demonstrate non-inferiority of the IA compared with SoC arm. Women in the IA took more treatment doses compared with the SoC group (113/124 (91%) vs 75/117 (64%), p=0.0001), but were more likely to experience diarrhoea (61% vs 24%, p<0.0001). Of 288 samples available for analysis, Mycoplasma genitalium was identified in 10% (28/288), 58% (11/19) of which had baseline antimicrobial resistance-associated mutations.ConclusionA short-course azithromycin-based regimen is likely to be less effective than the standard treatment with ofloxacin plus metronidazole. The high rate of baseline antimicrobial resistance supports resistance testing in those with M. genitalium infection to guide appropriate therapy.Trial registration number2010-023254-36.

An audit on the management of pelvic inflammatory disease in the West Midlands, UK

2007 ◽  
Vol 18 (10) ◽  
pp. 717-719 ◽  
Author(s):  
M Walzman ◽  
A Tariq ◽  
S Bhaduri ◽  
J D C Ross
Keyword(s):  
Data Collection ◽  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
National Standards ◽  
National Standard ◽  
Standards Of Care ◽  
National Guidelines ◽  
The West ◽  
West Midlands

The potential complications of pelvic inflammatory disease (PID) make optimizing its management a high priority. A clinical audit of PID against current national management guidelines was conducted in 14 departments of genitourinary medicine in the West Midlands for women presenting with PID between January and December 2005. There were a total of 810 diagnoses of PID made from a total of 49,390 female attendees for that year, giving an incidence of 164 cases per 10,000 attendees. Of these 810 cases, data collection and analysis for this audit were performed on 139. An ofloxacin 400 mg twice daily (b.i.d.) based regimen was prescribed in 91 (65%, 95% confidence interval [CI] 57–73%) cases. Doxycycline 100 mg b. i. d. for 14 days plus metronidazole 400 mg b. i. d. for 5–14 days was prescribed in 44 (32%, 95% CI 25–40%) cases, but a third-generation cephalosporin was only given with this regimen in three cases. Partner notification was performed in 101 (73%, 95% CI 65–79%) cases. A total of 130 male contacts were recorded on the data collection forms, and of these 58 (45%) were traced and 51 (39%), treated. A follow-up appointment was given to 133 (96%, 95% CI 91–98%) women, although in most cases this was for seven days or more, and 104 (78%, 95% CI 67–81%) women attended for follow-up. Adherence to the national guidelines in this cohort of patients did not reach the national standard for choice of treatment regimen nor did it attain the target for proportion of male partners traced. Barriers preventing adherence to the national guidelines need to be explored and appropriate assistance given to physicians to help meet national standards of care.

scholarly journals ASPEK ETIK DAN HUKUM KERAHASIAAN PASIEN COVID-19

2021 ◽  
pp. 88-97
Author(s):  
Sutrisno dr ◽  
Ali Taufan
Keyword(s):  
Literature Review ◽  
Virus Disease ◽  
Google Scholar ◽  
Corona Virus

Kondisi pandemi Corona virus disease (Covid-19) yang semakin memburuk bukan hanya masalah medis saja, namun juga masalah kerahasiaan pasien yang juga berpengaruh terhadap usaha menekan penyebaran Covid-19. Timbul pertanyaan apakah pasien Covid-19 berhak memperoleh perlindungan hak kerahasiaan atau hak kerahasiaan ini dapat dikesampingkan untuk kepentingan yang lebih luas dalam pencegahan penyebaran Covid-19. Jurnal yang digunakan dalam literature review didapatkan melalui database penyedia jurnal Scientific melalui google scholar. Dari literatur yang didapatkan secara etik adanya kewajiban moral dalam hal mencegah stigmatisasi, diskriminasi, dan kesalahan dalam menyebarluaskan informasi terkait Covid-19. Kewajiban untuk melindungi rahasia pasien tidak bersifat mutlak, dan dapat dikecualikan bila ada kondisi yang membahayakan masyarakat luas yang diatur dalam etika kesehatan masyarakat. Undang-undang kesehatan di beberapa negara seperti di Amerika memberikan pengecualian terhadap kerahasiaan data pasien apabila berhubungan dengan kepentingan umum maka kerahasiaan pasien dapat dibuka. Hal ini akan sejalan dengan kondisi saat ini dikarenakan penyebaran virus Covid-19 telah menjadi bencana. Telaah pustaka ini dilakukan karena sangat pentingnya suatu pedoman etik, dan peraturan kerahasiaan pasien khususnya pasien Covid-19 yang melindungi kedua belah pihak, dan adanya kepastian hukum perikatan dokter dan pasien.

scholarly journals Penanganan Stroke Iskemik Akut di Masa Pandemi COVID-19

e-CliniC ◽  
2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Erlika Lengkong ◽  
Finny Warouw ◽  
Mieke A. H. N. Kembuan
Keyword(s):  
Ischemic Stroke ◽  
Literature Review ◽  
Acute Ischemic Stroke ◽  
Personal Protective Equipment ◽  
Virus Disease ◽  
Google Scholar ◽  
Protective Equipment ◽  
Team Approach ◽  
Long Distance ◽  
Corona Virus

Abstract: When the pandemic corona virus disease (COVID-19) occurs, emergency services and hospitals are finally disrupted. One of the medical emergencies which can cause death and disability as well as other problems if being ignored, especially in productive age patients is stroke. This study was aimed to obtain the management of ischemic stroke during COVID-19 pandemic. This was a literature review study using three databases, namely Clinical Key, PubMed and Google Scholar. The keywords used in data search were acute AND stroke AND pandemic. The results showed that the treatment of acute ischemic stroke during COVID-19 pandemic consisted of three stages, namely pre-hospitalization (public education, contacting medical assistance, use of personal protective equipment, pre-notification), hospitalization (emergency room, imaging room, neuroradiology unit, ICU and IMCU), and post hospitalali-zation (integrated team approach). In conclusion, the management of acute ischemic stroke during COVID-19 pandemic begins before the medical personnel take action until the action is carried out. The main things in the management of acute ischemic stroke during COVID-19 pandemic are handling fast and precisely, using adequate personal protective equipment (PPE), and using communication tools or long-distance medical care (telemedicine).Keywords: acute ischemic stroke, COVID-19, pandemic Abstrak: Saat terjadi pandemi corona virus disease (COVID-19), layanan kegawatdaruratan dan rumah sakit megalami perubahan. Salah satu kasus kegawatdaruratan medik yang menjadi penyebab kematian dan kecacatan serta dapat menimbulkan masalah lainnya jika diabaikan terutama pada pasien usia produktif ialah stroke. Penelitian ini bertujuan untuk mengetahui penanganan stroke pada masa pandemic COVID-19. Jenis penelitian ialah literature review yang menggunakan tiga database yaitu Clinikal key, PubMed dan Google Scholar. Kata kunci yang digunakan dalam pencarian data ialah acute AND stroke AND pandemic. Hasil penelitian mendapatkan penanganan stroke iskemik akut di masa pandemi COVID-19 terdiri dari 3 tahapan yakni prahospitalisasi (edukasi masyarakat, menghubungi bantuan medis, penggunaan alat pelindung diri, pranotifikasi rumah sakit), hospitalisasi (ruang gawat darurat, ruang pencitraan, unit neuroradiologi, ICU dan IMCU), dan pasca hospitalisasi (pendekatan tim terpadu). Simpulan penelitian ini ialah penanganan stroke iskemik akut di masa pandemi COVID-19 dimulai dari sebelum tenaga medis melakukan tindakan sampai setelah tindakan dilaksanakan. Hal utama dalam penanganan stroke iskemik akut di masa pandemi COVID-19 ialah penanganan yang cepat dan tepat, penggunaan alat pelindung diri (APD) yang memadai, dan pemanfaatan alat komunikasi atau perawatan medis jarak jauh.Kata kunci: stroke iskemik akut, pandemi, COVID-19

scholarly journals A primer on the in-home teleneurologic examination

2020 ◽  
pp. 10.1212/CPJ.0000000000000876 ◽  
Author(s):  
Christopher J. Boes ◽  
Andrea N. Leep Hunderfund ◽  
Jennifer M. Martinez-Thompson ◽  
Neeraj Kumar ◽  
Rodolfo Savica ◽  
...  
Keyword(s):  
Virus Disease ◽  
Medical Professional ◽  
Clinical Question ◽  
Face To Face ◽  
Corona Virus ◽  
First Time

It is imperative in the corona virus disease 2019 (COVID-19) pandemic that we serve our patients by implementing teleneurology visits for those who require neurologic advice but do not need to be seen face-to-face. The authors propose a thorough, practical, in-home, teleneurologic examination that can be completed without the assistance of an on-the-scene medical professional, and can be tailored to the clinical question. We hope to assist trainees and practicing neurologists doing patient video visits for the first time during the COVID-19 pandemic, focusing on what can, rather than what cannot, be easily examined.

A multidistrict audit of the management of chlamydial PID in genitourinary medicine clinics in Yorkshire

2002 ◽  
Vol 13 (4) ◽  
pp. 264-267 ◽  
Author(s):  
Usha Kuchimanchi ◽  
Hugo McClean
Keyword(s):  
Pelvic Inflammatory Disease ◽  
Antibiotic Treatment ◽  
Inflammatory Disease ◽  
Partner Notification ◽  
Clinic Attendance ◽  
Referral Patterns ◽  
Genitourinary Medicine ◽  
Audit Reports ◽  
Partner Participation

In response to recent reviews of practice of pelvic inflammatory disease (PID) management, a multidistrict audit involving eight genitourinary clinics within the Yorkshire region was carried out. This audit reports the referral patterns of patients, physical signs and microscopy findings at the first genitourinary medicine (GUM) clinic attendance, antibiotic treatment and follow-up data as well as health adviser involvement and partner participation for 68 patients diagnosed with chlamydial PID. Twenty-eight (41.2%) patients presented with symptoms of less than or equal to four weeks duration, partner notification was recorded as being carried out for all patients and at least one partner was documented as having been treated in 57 (83.8%) patients. There is, however, a wide variation in the antibiotic regimens used for treatment and their duration.

Mortality Following a Psychiatric Emergency Room Visit: An 18-Month Follow-Up Study

1971 ◽  
Vol 128 (2) ◽  
pp. 220-224 ◽  
Author(s):  
RODRIGO A. MUNOZ ◽  
SUE MARTEN ◽  
KATHYE A. GENTRY ◽  
ELI ROBINS
Keyword(s):  
Emergency Room ◽  
Emergency Room Visit ◽  
Psychiatric Emergency ◽  
Psychiatric Emergency Room ◽  
Follow Up Study
Sign in / Sign up

Export Citation Format

Share Document